MedPath

Efficacy of Therapeutic Exercise vs. Treatment of Myofascial Trigger Points.

Not Applicable
Completed
Conditions
Shoulder Tendinopathy
Registration Number
NCT06241404
Lead Sponsor
Universidad Católica de Ávila
Brief Summary

Background: Shoulder pain commonly affects the general population, with rotator cuff tendinopathy being the most common cause.

the most common cause, with rotator cuff tendinopathy diminishing function and quality of life, leading to a major socio-economic impact.

quality of life, leading to a major socio-economic impact. As a result, there are two treatment approaches with potential effectiveness: therapeutic exercise (TE) and myofascial trigger point treatment (TMT).

trigger point treatment (TTP).

Objective: The main objective of this randomised clinical trial is to determine the efficacy of ET versus treatment of MTPs in shoulder tendinopathies.

Methods: For this study, 20 participants were randomly divided into two groups: a ET group, with which a 10-exercise programme was initiated (n = 10), and a PGM group which was given an intervention protocol (n = 10).

intervention protocol (n = 10). Both received a total of 10 sessions. Pain intensity pain intensity, pressure pain threshold (PPT) and range of motion (ROM) were assessed before starting and after 10 sessions.

and after 10 sessions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Signed informed consent form.
  • Patients diagnosed by an orthopaedic surgeon with shoulder tendinopathy. tendinopathy.
  • Symptoms of shoulder pain lasting more than 3 months.
  • Pain on Jobe, Patte and infraspinatus assessment manoeuvres (highlighting abduction and abduction and external rotation).
Exclusion Criteria
  • Previous shoulder surgery.
  • Radiating (non-referred) pain from cervical radiculopathy.
  • Shoulder pain associated with other diagnoses (Examples: retractile capsulitis, subacromial syndrome, tendon rupture, posterosuperior conflict, etc.).

subacromial syndrome, tendon rupture, posterosuperior conflict, etc).

  • Patients with multiple pathologies.
  • Patients with neurological disorders.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Range of motionAt the end of Session 10 (each Session is 7 days)

measurement of shoulder range of motion

pain intensityAt the end of Session 10 (each Session is 7 days)

measured on a VAS scale where 0 is the minimum and 10 is the maximum.

Secondary Outcome Measures
NameTimeMethod
pressure pain thresholdAt the end of Session 10 (each Session is 7 days)

measured by algometer

Trial Locations

Locations (1)

Jorge Velázquez Saornil

🇪🇸

Ávila, Spain

Jorge Velázquez Saornil
🇪🇸Ávila, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.